[go: up one dir, main page]

AR120475A1 - Producción de células precursoras hematopoyéticas - Google Patents

Producción de células precursoras hematopoyéticas

Info

Publication number
AR120475A1
AR120475A1 ARP200103167A ARP200103167A AR120475A1 AR 120475 A1 AR120475 A1 AR 120475A1 AR P200103167 A ARP200103167 A AR P200103167A AR P200103167 A ARP200103167 A AR P200103167A AR 120475 A1 AR120475 A1 AR 120475A1
Authority
AR
Argentina
Prior art keywords
precursor cells
hematopoietic precursor
production
hematopoietic
runx1c
Prior art date
Application number
ARP200103167A
Other languages
English (en)
Inventor
Stuart Chambers
Jingli Zhang
Qingwen Cheng
Guanyi Huang
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR120475A1 publication Critical patent/AR120475A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente proporciona métodos mejorados para la generación de células precursoras hematopoyéticas a partir de una célula madre pluripotente y células precursoras hematopoyéticas generadas a partir de las mismas. Las células precursoras hematopoyéticas expresan CXCR4 o runx1c y son capaces de migrar a, y/o injertarse en, la médula ósea.
ARP200103167A 2019-11-14 2020-11-16 Producción de células precursoras hematopoyéticas AR120475A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962935353P 2019-11-14 2019-11-14

Publications (1)

Publication Number Publication Date
AR120475A1 true AR120475A1 (es) 2022-02-16

Family

ID=73790249

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200103167A AR120475A1 (es) 2019-11-14 2020-11-16 Producción de células precursoras hematopoyéticas

Country Status (9)

Country Link
US (1) US20220411755A1 (es)
EP (1) EP4058564A1 (es)
JP (1) JP2023501520A (es)
AR (1) AR120475A1 (es)
AU (1) AU2020381537A1 (es)
CA (1) CA3161465A1 (es)
MX (1) MX2022005892A (es)
TW (1) TW202132563A (es)
WO (1) WO2021097346A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4251741A1 (en) 2020-11-30 2023-10-04 CRISPR Therapeutics AG Gene-edited natural killer cells
WO2022144632A1 (en) 2020-12-30 2022-07-07 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into nk cells
CN116445408B (zh) * 2023-05-22 2024-02-02 呈诺再生医学科技(北京)有限公司 LSD1抑制剂在促进iPSC向HSC分化和HSC干性维持中的应用
WO2025090879A1 (en) 2023-10-26 2025-05-01 Amgen Inc. Pluripotent cell differentiation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197915B (en) 1986-11-19 1990-11-14 Rolls Royce Plc Improvements in or relating to fluid bearings
JP5943533B2 (ja) 2000-05-17 2016-07-06 アステリアス バイオセラピューティクス インコーポレイテッド 神経前駆細胞の集団
JP6189581B2 (ja) * 2009-02-20 2017-08-30 セルラー ダイナミクス インターナショナル， インコーポレイテッド 幹細胞の分化のための方法および組成物
BR112013003366A2 (pt) * 2010-08-12 2020-08-04 Fate Therapeutics, Inc. terapia aperfeiçoada de células tronco hematopoiéticas e progenitoras
AU2016348342B2 (en) * 2015-11-04 2023-07-06 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
US11261430B2 (en) * 2016-05-03 2022-03-01 The Children's Medical Center Corporation Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells
ES3009587T3 (en) * 2016-05-13 2025-03-27 Murdoch Childrens Res Inst Haematopoietic stem/progenitor cells

Also Published As

Publication number Publication date
US20220411755A1 (en) 2022-12-29
CA3161465A1 (en) 2021-05-20
JP2023501520A (ja) 2023-01-18
MX2022005892A (es) 2022-06-14
AU2020381537A1 (en) 2022-06-09
TW202132563A (zh) 2021-09-01
EP4058564A1 (en) 2022-09-21
WO2021097346A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
AR120475A1 (es) Producción de células precursoras hematopoyéticas
BR112014032074A2 (pt) construções de tecido conjuntivo tridimensionais engendradas e métodos de fabricar as mesmas
MX2018005274A (es) Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
AR077767A1 (es) Diferenciacion de celulas madre embrionarias humanas
BR112015019950A2 (pt) Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro
CL2021000208A1 (es) Método para producir células derivadas de pulpa dental
MX2017000704A (es) Generacion de un banco de celula estromal mesenquimal a partir de celulas mononucleares agrupadas de multiples donadores de medula osea.
AR077369A1 (es) Metodopara producir eritrocitos sin celulas alimentadoras
MX355340B (es) Diferenciación de células madre embrionarias humanas.
MX2019008872A (es) Prevencion y tratamiento de da?o o enfermedad osea y cartilago.
GB2434157A (en) Platelets from stem cells
MY199613A (en) Cell population for transplantation and method for producing same
BR112013004514A2 (pt) diferenciação das células-tronco embrionárias humanas
MX383334B (es) Celulas discogenicas aisladas, metodos de uso, y metodos de preparacion de las mismas a partir de tejido de mamifero.
MX2018006373A (es) Produccion de virus en cultivos celulares.
MY184796A (en) Method for manufacturing ciliary marginal zone-like structure
EP3812457A4 (en) Method for preparing pellets of chondrocytes from human induced pluripotent stem cells, and use thereof
MX2018003354A (es) Seleccion de celulas pluripotentes para producir ratones hembra xy fertiles.
SG11201806177QA (en) Transplant material for treatment of heart disease
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells
MX2020008897A (es) Expansion y diferenciacion de citoblastos.
MY199770A (en) Method for culturing cord blood-derived natural killer cells using transformed t cells
PE20220003A1 (es) Metodo para la prediccion de eficacia del tratamiento de hemoglobinopatia
EP4235175A3 (en) Methods for culturing human keratinocytes
WO2014046704A3 (en) Adipose tissue graft for wound healing